Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic.

Metabolic brain disease·2026
Same author

Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression.

Molecular psychiatry·2026
Same author

Copper isotope shifts in biofluids track Alzheimer's pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Anti-amyloid immunotherapies in Alzheimer's disease: Are future prescribers prepared? Insights of a French national survey.

Journal of Alzheimer's disease : JAD·2026
Same author

Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology.

Cell press blue·2026
Same author

Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approach.

Alzheimer's research & therapy·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Alberto Jaramillo-Jimenez1,2,3,4, Yorguin Jose Mantilla-Ramos2,4,5, Diego Tovar1,6

  • 1Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

休息状态EEG分析揭示了神经退行性疾病中明显的模式. 莱维体痴呆症显示脑电波减慢和非周期性活动增加,而阿尔茨海默病则表现出较轻微的异常.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 电脑电图 (电脑电图) 是一种脑电图.

背景情况:

  • 静止状态EEG (rsEEG) 的α节律变化是神经退行性疾病 (NDD) 的潜在生物标志物.
  • 在光谱分析中,rsEEG的非周期性成分经常被忽视.
  • 多中心研究面临着批量效应的挑战,需要协调以进行可靠的分析.

研究的目的:

  • 在各种NDD中区分rsEEG振荡和无周期变化.
  • 通过协调,减轻多中心rsEEG数据中的批量效应.
  • 为了识别特定的EEG签名对于像Lewy体痴呆症 (LBD) 和阿尔茨海默病 (AD) 这样的疾病.

主要方法:

  • 来自12个地点的1750名受试者的rsEEG数据使用reComBat.com进行了预处理和协调.
  • 振荡和非周期性参数从协调后方功率频谱中使用specparam提取.
  • 分析了群体差异,使用引导对对对比,排列测试和后勤回归.

主要成果:

  • 协调有效地减少了rsEEG后置功率频谱中的批量效应.
  • 与其他组相比,莱维体痴呆症 (LBD) 的特点是更的无周期性参数和较低的振荡中心频率.
  • 与健康对照组 (HC) 和帕金森病 (PD) 相比,阿尔茨海默氏病 (AD) 的振荡阿尔法功率降低.

结论:

  • 数据协调有效地减轻了rsEEG光谱分析中的批量效应.
  • LBD表现出显著的振荡减速和增加的非周期性活动.
  • 阿尔茨海默病呈现出振荡和非周期性异常,尽管与LBD相比,效果大小较小.